Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BIO Bio-Rad Laboratories, Inc. daily Stock Chart
BIO [NYSE]
Bio-Rad Laboratories, Inc.
Healthcare | Medical Laboratories & Research | USA
financial highlights | statements
Index- P/E6.80 EPS (ttm)39.78 Insider Own3.30% Shs Outstand28.92M Perf Week8.64%
Market Cap7.82B Forward P/E39.60 EPS next Y6.83 Insider Trans-0.52% Shs Float21.48M Perf Month14.28%
Income1.20B PEG0.18 EPS next Q1.77 Inst Own78.80% Short Float2.50% Perf Quarter0.56%
Sales2.29B P/S3.41 EPS this Y83.40% Inst Trans1.61% Short Ratio2.47 Perf Half Y-15.55%
Book/sh164.10 P/B1.65 EPS next Y24.34% ROA21.60% Target Price328.60 Perf Year9.05%
Cash/sh29.78 P/C9.08 EPS next 5Y37.10% ROE30.00% 52W Range220.05 - 345.15 Perf YTD16.42%
Dividend- P/FCF52.97 EPS past 5Y-21.30% ROI1.90% 52W High-21.67% Beta1.23
Dividend %- Quick Ratio3.20 Sales past 5Y0.90% Gross Margin53.70% 52W Low22.85% ATR5.27
Employees8150 Current Ratio4.50 Sales Q/Q2.10% Oper. Margin7.40% RSI (14)75.07 Volatility2.39% 2.00%
OptionableYes Debt/Eq0.09 EPS Q/Q1120.50% Profit Margin55.50% Rel Volume1.24 Prev Close261.42
ShortableYes LT Debt/Eq0.09 EarningsFeb 28 AMC Payout0.00% Avg Volume217.01K Price270.34
Recom2.00 SMA209.55% SMA5011.28% SMA200-3.96% Volume268,873 Change3.41%
Oct-17-18Initiated Goldman Buy $350
Sep-20-18Initiated Morgan Stanley Equal-Weight $335
Feb-16-18Downgrade CL King Buy → Neutral
Jul-13-17Initiated Wells Fargo Outperform
Jun-28-17Upgrade Deutsche Bank Hold → Buy $220 → $255
Jan-18-17Initiated Deutsche Bank Hold $195
Oct-13-16Initiated CL King Buy
May-06-15Reiterated Jefferies Buy $150 → $165
Dec-18-09Initiated Maxim Group Buy $125
Nov-06-09Initiated Jefferies & Co Buy $130
Jul-17-09Initiated Soleil Buy $91
Sep-26-07Initiated Banc of America Sec Buy $110
Feb-23-07Downgrade Robert W. Baird Outperform → Neutral $83 → $76
Feb-15-19 07:30AM  The typical Facebook employee earns double Silicon Valley's median household income. How 50+ big tech employers compare American City Business Journals
Feb-14-19 07:28PM  Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response Business Wire
Feb-12-19 06:31PM  Bio-Rad to Report Fourth-Quarter and Full-Year 2018 Financial Results Thursday, February 28, 2019 Business Wire
Feb-04-19 07:50AM  Report: Developing Opportunities within T-Mobile US, Noble, Akebia Therapeutics, Vornado Realty Trust, Bio-Rad Laboratories, and Standex International Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-29-19 10:14AM  Bio-Rad Laboratories, Inc. (NYSE:BIO): A Fundamentally Attractive Investment Simply Wall St.
Jan-15-19 07:30AM  This is how much Apple pays a typical employee and how that compares to Google, Facebook, Netflix, Microsoft, Box and more American City Business Journals
Jan-03-19 04:30PM  Christine Tsingos Announces Plans to Retire as CFO of Bio-Rad Laboratories, Inc. Effective April 30, 2019 Business Wire
09:10AM  Luminex Buys MilliporeSigma's Flow Cytometry Unit for $75M Zacks
Jan-02-19 06:10PM  Bio-Rad to Participate at the 37th Annual J.P. Morgan Healthcare Conference on January 8 Business Wire
Dec-09-18 03:00AM  Hedge Funds Are Crazy About Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Dec-03-18 08:30AM  Bio-Rad Quality Controls Now Available for Multiple Abbott Clinical Diagnostics Platforms Business Wire
Nov-30-18 08:25AM  New Research Coverage Highlights Omeros, Apple, Bio-Rad Laboratories, Cott, Darling Ingredients, and Osisko Gold Royalties Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-14-18 08:55AM  Bio-Rad Clinches USDA Contract, Boosts Life Science Segment Zacks
08:30AM  Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies Business Wire
Nov-13-18 08:30AM  Bio-Rad Wins USDA Contract for Its Pathogen Detection Testing Products Business Wire
Nov-12-18 10:07PM  GBT Reports Third Quarter And 9M18 Results PR Newswire
Nov-03-18 06:16PM  Edited Transcript of BIO earnings conference call or presentation 1-Nov-18 9:00pm GMT Thomson Reuters StreetEvents
Nov-02-18 10:50AM  Bio-Rad (BIO) Earnings Miss Estimates in Q3, Revenues Beat Zacks
05:12AM  Bio-Rad: 3Q Earnings Snapshot Associated Press
Nov-01-18 09:25PM  Bio-Rad Laboratories Inc (BIO) Q3 2018 Earnings Conference Call Transcript Motley Fool
09:00PM  Bio-Rad Laboratories (BIO) Q3 Earnings Lag Estimates Zacks
07:54PM  Bio-Rad: 3Q Earnings Snapshot Associated Press
04:30PM  Bio-Rad Reports Third-Quarter 2018 Financial Results Business Wire
08:05AM  Boasting A 22% Return On Equity, Is Bio-Rad Laboratories Inc (NYSE:BIO) A Top Quality Stock? Simply Wall St.
Oct-29-18 08:30AM  Bio-Rad Receives U.S. FDA Clearance for the IH-Reader 24, Expanding the Companys Offering for the Blood Typing Market Business Wire
Oct-23-18 09:56AM  Leaning on tech expertise, Peninsula gene-editing company raises $110 million, targets lower-priced drugs American City Business Journals
07:20AM  Research Report Identifies Nordson, Willis Towers Watson Public, Bio-Rad Laboratories, Insperity, SAP SE, and Wesco Aircraft with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Oct-16-18 10:47AM  What's in Store for Cerner (CERN) This Earnings Season? Zacks
Oct-09-18 12:00PM  Bio-Rad to Report Third-Quarter 2018 Financial Results Thursday, November 1, 2018 Business Wire
07:30AM  Biome Grow to begin trading on the Canadian Securities Exchange under the symbol BIO GlobeNewswire
Sep-14-18 10:09AM  What You Must Know About Bio-Rad Laboratories Incs (NYSE:BIO) Financial Health Simply Wall St.
Sep-06-18 10:15AM  Bio-Rad (BIO) Down 0.3% Since Last Earnings Report: Can It Rebound? Zacks
Aug-29-18 07:27PM  Bio-Rad to Participate at the Morgan Stanley 16th Annual Global Healthcare Conference on September 12 Business Wire
Aug-24-18 04:23AM  Here's Why You Should Steer Clear of AmerisourceBergen Now (Revised) Zacks
Aug-21-18 01:40PM  Edited Transcript of BIO earnings conference call or presentation 7-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-14-18 10:16AM  Bio-Rad (BIO) Banks on Blood Typing Market Amid Margin Woes Zacks
Aug-09-18 09:09AM  Bio-Rad (BIO) Tops Earnings and Revenue Estimates in Q2 Zacks
Aug-07-18 08:20PM  Bio-Rad Laboratories (BIO) Beats Q2 Earnings and Revenue Estimates Zacks
07:20PM  Bio-Rad: 2Q Earnings Snapshot Associated Press
04:49PM  Bio-Rad Reports Second-Quarter 2018 Financial Results Business Wire
03:00PM  Bio-Rad Laboratories, Inc. Class A to Host Earnings Call ACCESSWIRE
Jul-26-18 07:16AM  Get Sweet Surprise on Earnings From 5 Top-Ranked Stocks Zacks
Jul-25-18 07:45AM  Report: Developing Opportunities within Acxiom, BofI Holding, On Assignment, Marriot Vacations Worldwide, Bio-Rad Laboratories, and Dime Community Bancshares Future Expectations, Projections Moving into 2018 GlobeNewswire
Jul-16-18 01:49PM  Bio-Rad to Report Second-Quarter 2018 Financial Results Tuesday, August 7, 2018 Business Wire
Jul-12-18 09:30AM  Is Bio-Rad Laboratories (BIO) Outperforming Other Medical Stocks This Year? Zacks
Jul-06-18 09:36AM  Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
Jul-05-18 03:17PM  Here's Why You Should Invest in Baxter (BAX) Stock Right Now Zacks
Jul-03-18 01:30PM  Bio-Rad Laboratories, Inc. -- Moody's affirms Bio-Rad's Baa3 senior unsecured rating; changes outlook to positive from stable Moody's
Jun-25-18 08:00AM  Is Bio-Rad Laboratories Inc (NYSE:BIO) A Buy At Its Current PE Ratio? Simply Wall St.
Jun-08-18 09:14AM  Bio-Rad Banks on Solid Global Scenario, Competition Rife Zacks
Jun-05-18 07:10AM  Wired News - LabCorp Collaborates with Unilabs to Expand Development and Reach of Precision Medicine Capabilities ACCESSWIRE
May-30-18 08:02PM  Bio-Rad to Present at Jefferies 2018 Global Healthcare Conference on June 5 Business Wire
May-29-18 09:58AM  Bio-Rad (BIO) Up 13.5% in 3 Weeks Post Solid Q1 Earnings Zacks
May-18-18 08:00AM  Research Report Identifies Bio-Rad Laboratories, Bright Horizons Family Solutions, Corbus Pharmaceuticals, PennyMac Financial Services, TeleTech, and Matrix Service with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
May-10-18 03:56PM  Edited Transcript of BIO earnings conference call or presentation 8-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-08-18 07:56PM  Bio-Rad: 1Q Earnings Snapshot Associated Press
04:25PM  Bio-Rad Reports First Quarter 2018 Financial Results Business Wire
01:31AM  Medical Product Stocks May 8 Earnings List: HSIC, PEN & More Zacks
Apr-30-18 10:08AM  3 Reasons Why You Should Invest in Baxter International Now Zacks
Apr-26-18 03:49PM  Integra LifeSciences (IART) Tops on Q1 Earnings, '18 View Up Zacks
Apr-25-18 03:19PM  LabCorp (LH) Beats on Q1 Earnings, Revenues, Lifts '18 View Zacks
12:33PM  Thermo Fisher (TMO) Q1 Earnings Beat Estimates, '18 View Up Zacks
12:12PM  Illumina (ILMN) Beats on Q1 Earnings, Lifts '18 Guidance Zacks
11:14AM  Edwards Lifesciences (EW) Q1 Earnings Beat, Revenues Miss Zacks
10:53AM  Boston Scientific (BSX) Beats on Q1 Earnings, Lifts '18 View Zacks
Apr-24-18 11:50AM  Why BIOTON SA.s (WSE:BIO) Investor Composition Impacts Your Returns Simply Wall St.
Apr-20-18 10:45AM  Here's Why You Should Invest in Integer Holdings Right Now Zacks
08:11AM  Here's Why You Should Invest in Stryker (SYK) Right Now Zacks
07:43AM  Chemed (CHE) Beats on Q1 Earnings & Revenues, Retains View Zacks
Apr-19-18 10:08AM  Quest Diagnostics (DGX) Q1 Earnings Meet, Guidance Intact Zacks
Apr-18-18 04:24PM  Bio-Rad to Report First-Quarter 2018 Financial Results Business Wire
11:14AM  Abbott (ABT) Q1 Earnings & Revenues Top, '18 View Retained Zacks
10:12AM  Intuitive Surgical (ISRG) Beats on Q1 Earnings & Revenues Zacks
Apr-13-18 08:55AM  Express Scripts (ESRX) to Launch Pilot Program, Shares Up Zacks
Apr-12-18 01:15PM  Where BIOTON SA. (WSE:BIO) Stands In Earnings Growth Against Its Industry Simply Wall St.
08:46AM  Can Solid EPD Business Drive Abbott's (ABT) Q1 Earnings? Zacks
Apr-11-18 12:00PM  Haemonetics Rides High on Plasma, Blood Center Remains Weak Zacks
09:48AM  Masimo Gets CE Mark for NomoLine, Expands in Capnography Zacks
09:44AM  Here's Why You Should Hold on to Ecolab (ECL) Stock for Now Zacks
09:08AM  Varian Medical (VAR) Launches Velocity 4.0, Shares Rise Zacks
Apr-10-18 10:16AM  Texas Hospital Administers Cerner's (CERN) Millenium System Zacks
09:01AM  Here's Why You Should Invest in Fresenius Medical Right Now Zacks
Apr-09-18 11:08AM  GNC Holdings Partners Rapid Nutrition, Forays in Australia Zacks
09:40AM  Stryker Loses 7.6% in a Month: What's Weighing It Down? Zacks
Apr-06-18 10:54AM  Hill-Rom Banks on Product Innovation, Strategic Buyouts Zacks
09:56AM  Cerner's EHR to Aid Kern Medical's Population Management Zacks
Apr-05-18 11:26AM  Align Unveils Vivera Retainers for Deep Bite Correction Zacks
10:08AM  Align Technology Broadens Invisalign Suite, Extends Reach Zacks
10:02AM  ABIOMED's (ABMD) Impella 5.5 Receives CE Mark in Europe Zacks
Apr-04-18 11:21AM  Myriad Genetics' BRACAnalysis Test Platform Gets PMA in Japan Zacks
10:55AM  Masimo (MASI) Launches UniView, Improves Patient Safety Zacks
10:52AM  Here's Why You Should Invest in ABIOMED (ABMD) Right Now Zacks
10:35AM  Cooper (COO) Buys LifeGlobal to Widen Fertility Device Line Zacks
Apr-03-18 03:01PM  FDA Nod for Abiomed Impella CP with SmartAssist Widens Suite Zacks
10:51AM  IRCCO Picks Cerner's HealtheIntent for Patients of Illinois Zacks
10:25AM  AngioDynamics (ANGO) Product Line Strong, Debt Level High Zacks
Apr-02-18 11:03AM  Haemonetics' Plasma Tool Enhancement Gets 510(K) Clearance Zacks
10:05AM  Here's Why You Should Invest in Masimo (MASI) Right Now Zacks
Mar-29-18 10:27AM  Global Expansion and Product Launches to Aid ResMed's Growth Zacks
09:38AM  Accuray Radixact Picked by India's Apollo for Cancer Treatment Zacks
Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crowley MichaelEVP, GBL Commercial OperationsDec 14Sale248.0339297,2283,425Dec 14 07:00 PM
TSINGOS CHRISTINE AEVP and CFODec 14Sale248.001,411349,9286,683Dec 17 11:20 AM
STARK JAMES RVP, Corporate ControllerDec 12Sale254.77848216,0450Dec 12 05:16 PM
TUMOLO ANNETTEExecutive Vice PresidentDec 11Option Exercise159.321,200191,1842,704Dec 12 05:07 PM
TUMOLO ANNETTEExecutive Vice PresidentDec 11Sale254.512,376604,7041,504Dec 12 05:07 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 11Option Exercise0.001,00003,027Sep 13 04:38 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 11Option Exercise0.005,8000264,465Sep 13 04:22 PM
TSINGOS CHRISTINE AEVP and CFOSep 11Option Exercise0.0066008,323Sep 13 04:17 PM
STARK JAMES RVP, Corporate ControllerSep 11Option Exercise0.0050001,022Sep 13 04:13 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 11Option Exercise0.00740012,287Sep 13 04:08 PM
HUTTON RONALD WVice President and TreasurerSep 11Option Exercise0.0030004,104Sep 13 04:01 PM
HERTIA JOHNExecutive Vice PresidentSep 11Option Exercise0.001,300015,038Sep 13 03:57 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 11Option Exercise0.0097604,156Sep 13 03:53 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 10Option Exercise0.002,0000259,657Sep 12 07:39 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 10Option Exercise0.0038903,315Sep 12 05:10 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 10Option Exercise0.0040002,166Sep 12 05:06 PM
TSINGOS CHRISTINE AEVP and CFOSep 10Option Exercise0.0040007,802Sep 12 05:00 PM
STARK JAMES RVP, Corporate ControllerSep 10Option Exercise0.002000592Sep 12 04:55 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 10Option Exercise0.00400011,746Sep 12 04:51 PM
HUTTON RONALD WVice President and TreasurerSep 10Option Exercise0.0015003,856Sep 12 04:48 PM
HERTIA JOHNExecutive Vice PresidentSep 10Option Exercise0.00600013,946Sep 12 04:10 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 08Option Exercise0.00400011,545Sep 11 02:28 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 07Option Exercise0.0060001,974Sep 11 02:46 PM
TSINGOS CHRISTINE AEVP and CFOSep 07Option Exercise0.0050007,575Sep 11 02:43 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 07Option Exercise0.003,0000259,145Sep 11 02:38 PM
STARK JAMES RVP, Corporate ControllerSep 07Option Exercise0.003000496Sep 11 02:33 PM
HUTTON RONALD WVice President and TreasurerSep 07Option Exercise0.0017003,765Sep 11 02:20 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 07Option Exercise0.0050001,372Sep 11 01:42 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 07Option Exercise0.0060003,134Sep 11 01:28 PM
HERTIA JOHNExecutive Vice PresidentSep 07Option Exercise0.00600013,554Sep 11 02:02 PM
HERTIA JOHNExecutive Vice PresidentSep 05Option Exercise0.00600013,162Sep 07 02:43 PM
TUMOLO ANNETTEExecutive Vice PresidentSep 05Option Exercise0.0060001,582Sep 07 02:41 PM
TSINGOS CHRISTINE AEVP and CFOSep 05Option Exercise0.0060007,283Sep 06 08:12 PM
STARK JAMES RVP, Corporate ControllerSep 05Option Exercise0.003000300Sep 06 08:08 PM
SCHWARTZ NORMAN DChairman, President, and CEOSep 05Option Exercise0.002,6000413,852Sep 06 08:05 PM
Magni GiovanniEVP, Chief Strategy OfficerSep 05Option Exercise0.00500011,333Sep 06 08:02 PM
HUTTON RONALD WVice President and TreasurerSep 05Option Exercise0.0018003,658Sep 06 08:00 PM
ERNST TIMOTHY SEVP, General Counsel & SecSep 05Option Exercise0.0050001,045Sep 06 07:57 PM
Crowley MichaelEVP, GBL Commercial OperationsSep 05Option Exercise0.0060002,742Sep 06 07:53 PM
Crowley MichaelEVP, GBL Commercial OperationsJun 13Sale303.42350106,1972,142Jun 14 01:23 PM
SCHWARTZ NORMAN DChairman, President and CEOMay 11Option Exercise88.4837,5003,318,000280,418May 11 08:47 PM
Magni GiovanniEVP, Chief Strategy OfficerMay 11Option Exercise88.003,500308,00012,751May 11 08:41 PM
open in yahoo | open in reuters | open in google